Barclays Maintains Overweight on Elanco Animal Health, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad maintains an Overweight rating on Elanco Animal Health but lowers the price target from $22 to $19.
October 28, 2024 | 2:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Balaji Prasad maintains an Overweight rating on Elanco Animal Health but lowers the price target from $22 to $19.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some concerns about future performance. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100